Revenue Milestones. WESTMŸN’s Monthly Revenue Milestones shall be:
Revenue Milestones. (i) $2 million to be paid after the recognition of $7.8 million in Net Revenues (“Revenue Milestone 1”) for the period beginning on July 1, 2007, but only if Revenue Milestone 1 is achieved on or before March 31, 2008;
(ii) $3 million to be paid after the recognition of $29.5 million in Net Revenues (“Revenue Milestone 2”) for the period beginning on July 1, 2007, but only if Revenue Milestone 2 is achieved on or before June 30, 2009; and
(iii) $4.9 million to be paid after the recognition of $56.7 million in Net Revenues (“Revenue Milestone 3”) for the period beginning on July 1, 2007, but only if Revenue Milestone 3 is achieved on or before December 31, 2010.
Revenue Milestones. Subject to Section 7.6, within one hundred five (105) days following the end of any calendar year through and including the calendar year ending December 31, 2024 (the “Final Milestone Date”) in which any of the following annual Net Sales targets is first achieved, Purchaser shall, at its election, (i) pay the cash amount listed next to such target below (for purposes of this subsection, the “Earn-Out Value”) to Seller, (ii) deliver to Seller a number of Earn-Out Shares determined by dividing such Earn-Out Value by the Opko Milestone Trading Value or (iii) pay a portion of such Earn-Out Value in cash and a portion in Earn-Out Shares (determined by dividing such portion by the Opko Milestone Trading Value) in its discretion. US$*** US$*** US$*** US$*** US$*** US$*** For purposes of this Section, annual Net Sales shall be calculated on a calendar-year basis following the completion of Opko Health’s audit of its annual financial statements for such year and certified to Seller by the Chief Financial Officer of Opko Health, provided that any Earn-Out Payment that is due pursuant to this subsection shall be paid within one hundred five (105) days following the end of any calendar year regardless of whether or not such audit is complete.
Revenue Milestones. The Company shall be allowed to request quarterly Advances of up to the lesser of (i) $250,000; or (ii) one sixth (1/6) of the revenue reported in the form 10-Q or form 10-K filed with the Securities and Exchange Commission for the previous calendar quarter or previous fiscal year, whichever is most recent, provided that such revenue generated a profit of at least ten percent (10%);
Revenue Milestones. A.) Future Wave Management, Inc. will be granted 500,000 warrants when the company’s revenue reaches $20 million and 500,000 warrants when the company’s revenue reaches $50 million. Exercise price will be at a 33% discount to the average trading price of the company’s stock for a period of 45 days prior to the attainment of the revenue milestones.
Revenue Milestones. CoTherix shall make the following milestone payments to Asahi within [***] after the date upon which the applicable milestone has been achieved:
(i) The sum of [***] upon the end of the first calendar year in which annual Net Sales of Oral Products and Inhaled Products combined in the PH Field first exceeds [***] within the Territory.
(ii) The sum of [***] upon the end of the first calendar year in which annual Net Sales of Oral Products in the Stable Angina Field first exceeds [***] within the Territory.
(iii) The sum of [***] upon the end of the first calendar year in which annual Net Sales of Oral Products and Inhaled Products combined in the PH Field first exceeds [***] within the Territory.
(iv) The sum of [***] upon the end of the first calendar year in which annual Net Sales of Oral Products in the Stable Angina Field first exceeds [***] within the Territory.
(v) The sum of [***] upon the end of the first calendar year in which annual Net Sales of Oral Products and Inhaled Products combined in the PH Field first exceeds [***] within the Territory.
(vi) The sum of [***] upon the end of the first calendar year in which annual Net Sales of Oral Products in the Stable Angina Field first exceeds [***] within the Territory.
(vii) The sum of [***]upon the end of the first calendar year in which annual Net Sales of Oral Products and Inhaled Products combined in the PH Field first exceeds [***] within the Territory. Allocation of Net Sales to the Stable Angina Field and PH Field shall be made by reference to IMS data (or if IMS no longer exists by reference to an at-least-as-reliable data source). * Confidential treatment has been requested as to certain portions of this agreement. Such omitted confidential information has been designated by asterisks and has been filed separately with the Securities and Exchange Commission.
Revenue Milestones. In the event of a Change of Control of Senseonics, Senseonics shall have the right to terminate this Agreement, effective upon [***] prior written notice, (i) in the event cumulative Net Sales under this Agreement have exceeded the projected revenue in the Revised Ascensia Revenue Case for the full Initial Term of the Agreement, and Ascensia has been compensated for the reasonable, non-cancellable internal and external costs relating to shutting down the associated operations, including for any costs incurred by Ascensia in connection with wind-down and transition activities under Section 7.3 (including reasonable costs of terminating Ascensia’s contracts or agreements with Subdistributors), or (ii) upon payment to Ascensia of a margin on the difference between the cumulative revenue to date and the projected revenue in the Revised Ascensia Revenue Case, which is intended to compensate Ascensia for its expected return on its investment in the promotion of the Products. This aforementioned margin will be calculated using the revenue sharing table set forth in Exhibit F-1 by simulating the volume of Products sold through the remaining periods or a similar method reasonably acceptable to the Parties at that point in time.
Revenue Milestones. MxXxxxxxxx will be granted 500,000 warrants when the company’s revenue reaches $20 million and 500,000 warrants when the Company’s revenue reaches $50 million. Exercise price will be at a 33% discount to the average trading price of the Company’s stock for a period of 45 days prior to the attainment of the revenue milestones.
Revenue Milestones. Licensee must achieve specific revenue milestones, as detailed in Appendix B, to maintain exclusivity. Failure to meet any of the defined milestones within the specified timeframes will permit Licensor to revoke or renegotiate the exclusivity rights granted herein.
Revenue Milestones. Upon PHYTOCHEM achieving the gross revenue milestones below, OM shall receive up to 20,000,000 unrestricted shares of the common stock of NTFU as follows: Revenue of $1,000,000 2,000,000 NTFU Common Shares Revenue of $5,000,000 2,000,000 NTFU Common Shares Revenue of $10,000,000 2,000,000 NTFU Common Shares Revenue of $25,000,000 4,000,000 NTFU Common Shares Revenue of $50,000,000 5,000,000 NTFU Common Shares Revenue of $100,000,000 5,000,000 NTFU Common Shares
